A detailed history of Endowment Wealth Management, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Endowment Wealth Management, Inc. holds 2,303 shares of ABBV stock, worth $421,287. This represents 0.33% of its overall portfolio holdings.

Number of Shares
2,303
Previous 2,216 3.93%
Holding current value
$421,287
Previous $380,000 19.47%
% of portfolio
0.33%
Previous 0.3%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

BUY
$163.84 - $199.33 $14,254 - $17,341
87 Added 3.93%
2,303 $454,000
Q2 2024

Aug 01, 2024

BUY
$154.79 - $180.76 $2,321 - $2,711
15 Added 0.68%
2,216 $380,000
Q1 2024

May 08, 2024

SELL
$159.82 - $182.1 $15,982 - $18,210
-100 Reduced 4.35%
2,201 $400,000
Q4 2023

Feb 07, 2024

SELL
$137.6 - $154.97 $44,857 - $50,520
-326 Reduced 12.41%
2,301 $356,000
Q3 2023

Oct 30, 2023

BUY
$133.59 - $154.65 $52,634 - $60,932
394 Added 17.64%
2,627 $391,000
Q2 2023

Aug 10, 2023

SELL
$132.51 - $164.9 $132 - $164
-1 Reduced 0.04%
2,233 $300,000
Q1 2023

May 10, 2023

SELL
$144.61 - $166.54 $54,084 - $62,285
-374 Reduced 14.34%
2,234 $356,000
Q4 2022

Feb 13, 2023

BUY
$138.31 - $165.87 $4,840 - $5,805
35 Added 1.36%
2,608 $421,000
Q3 2022

Nov 10, 2022

BUY
$134.21 - $153.93 $3,221 - $3,694
24 Added 0.94%
2,573 $345,000
Q2 2022

Aug 15, 2022

SELL
$137.62 - $174.96 $7,706 - $9,797
-56 Reduced 2.15%
2,549 $390,000
Q1 2022

May 04, 2022

SELL
$131.98 - $163.75 $53,979 - $66,973
-409 Reduced 13.57%
2,605 $422,000
Q4 2021

Feb 11, 2022

BUY
$107.43 - $135.93 $323,794 - $409,693
3,014 New
3,014 $408,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $323B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Endowment Wealth Management, Inc. Portfolio

Follow Endowment Wealth Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Endowment Wealth Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Endowment Wealth Management, Inc. with notifications on news.